CASC18

 

Full name: cancer susceptibility 18 Alias Symbol: LOC101929110
Type: non-coding RNA Cytoband: 12q23.3
Entrez ID: 101929110 HGNC ID: HGNC:49463 Ensembl Gene: ENSG00000257859 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of CASC18:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 CASC18 101929110 233190_at -0.1191 0.5682
GSE26886 CASC18 101929110 233190_at 0.3092 0.0580
GSE45670 CASC18 101929110 233190_at -0.0530 0.5174
GSE53622 CASC18 101929110 47385 0.1443 0.1338
GSE53624 CASC18 101929110 47385 -0.2627 0.0453
GSE63941 CASC18 101929110 233190_at 0.0201 0.8960
GSE77861 CASC18 101929110 233190_at -0.1455 0.0855

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by CASC18 expression:

 

GSE53622GSE53624

 

Note: Click image to view full size file.  


Copy number change of CASC18:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 CASC18 101929110 6 2 22
GSE20123 CASC18 101929110 6 2 22
GSE43470 CASC18 101929110 2 0 41
GSE46452 CASC18 101929110 9 1 49
GSE47630 CASC18 101929110 9 1 30
GSE54993 CASC18 101929110 0 5 65
GSE54994 CASC18 101929110 4 2 47
GSE60625 CASC18 101929110 0 0 11
GSE74703 CASC18 101929110 2 0 34
GSE74704 CASC18 101929110 3 2 15

Total number of gains: 41; Total number of losses: 15; Total Number of normals: 336.  


 

Somatic mutations of CASC18:

 

Generating mutation plots.

 

Highly correlated genes for CASC18:

 

Showing top 20/69 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
CASC18IQCF20.717721303
CASC18SLC22A310.704121303
CASC18CREB3L30.697015303
CASC18KDM80.685662303
CASC18SERPINA100.66244303
CASC18SLC32A10.657299403
CASC18DEFB108B0.653452404
CASC18TRIM100.653005303
CASC18WDR870.652197303
CASC18FGB0.64942303
CASC18GJD40.647846303
CASC18LINC012820.641961303
CASC18NOBOX0.641067303
CASC18CCDC1540.638769404
CASC18MMP190.636718303
CASC18PSPN0.634883303
CASC18RBBP8NL0.634759303
CASC18SLC26A10.634593303
CASC18RAPGEF30.630618303
CASC18KIF250.629079303

For details and further investigation, click here